Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 91.59%
March 31, 2026 90.92%
December 31, 2025 94.91%
September 30, 2025 70.44%
June 30, 2025 70.45%
March 31, 2025 61.61%
December 31, 2024 57.75%
September 30, 2024 44.67%
June 30, 2024 43.22%
March 31, 2024 46.63%
December 31, 2023 46.56%
September 30, 2023 45.58%
June 30, 2023 48.46%
Date Value
March 31, 2023 45.89%
December 31, 2022 40.52%
September 30, 2022 45.49%
June 30, 2022 39.74%
March 31, 2022 45.84%
December 31, 2021 46.51%
September 30, 2021 44.07%
June 30, 2021 44.58%
March 31, 2021 42.90%
September 30, 2020 64.51%
June 30, 2020 42.42%
March 31, 2020 45.32%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%
Veru, Inc. --
Johnson & Johnson 68.11%
Eli Lilly & Co. 85.78%

Gross Profit Margin (Quarterly) Related Metrics